Cargando…

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast

BACKGROUND: A major challenge in the interpretation of genomic profiling data generated from breast cancer samples is the identification of driver genes as distinct from bystander genes which do not impact tumorigenesis. One way to assess the relative importance of alterations in the transcriptome p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawthorn, Lesleyann, Luce, Jesse, Stein, Leighton, Rothschild, Jenniffer
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939551/
https://www.ncbi.nlm.nih.gov/pubmed/20799942
http://dx.doi.org/10.1186/1471-2407-10-460
_version_ 1782186735519662080
author Hawthorn, Lesleyann
Luce, Jesse
Stein, Leighton
Rothschild, Jenniffer
author_facet Hawthorn, Lesleyann
Luce, Jesse
Stein, Leighton
Rothschild, Jenniffer
author_sort Hawthorn, Lesleyann
collection PubMed
description BACKGROUND: A major challenge in the interpretation of genomic profiling data generated from breast cancer samples is the identification of driver genes as distinct from bystander genes which do not impact tumorigenesis. One way to assess the relative importance of alterations in the transcriptome profile is to combine parallel analyses that assess changes in the copy number alterations (CNAs). This integrated analysis permits the identification of genes with altered expression that map within specific chromosomal regions which demonstrate copy number alterations, providing a mechanistic approach to identify the 'driver genes'. METHODS: We have performed whole genome analysis of CNAs using the Affymetrix 250K Mapping array on 22 infiltrating ductal carcinoma samples (IDCs). Analysis of transcript expression alterations was performed using the Affymetrix U133 Plus2.0 array on 16 IDC samples. Fourteen IDC samples were analyzed using both platforms and the data integrated. We also incorporated data from loss of heterozygosity (LOH) analysis to identify genes showing altered expression in LOH regions. RESULTS: Common chromosome gains and amplifications were identified at 1q21.3, 6p21.3, 7p11.2-p12.1, 8q21.11 and 8q24.3. A novel amplicon was identified at 5p15.33. Frequent losses were found at 1p36.22, 8q23.3, 11p13, 11q23, and 22q13. Over 130 genes were identified with concurrent increases or decreases in expression that mapped to these regions of copy number alterations. LOH analysis revealed three tumors with whole chromosome or p arm allelic loss of chromosome 17. Genes were identified that mapped to copy neutral LOH regions. LOH with accompanying copy loss was detected on Xp24 and Xp25 and genes mapping to these regions with decreased expression were identified. Gene expression data highlighted the PPARα/RXRα Activation Pathway as down-regulated in the tumor samples. CONCLUSION: We have demonstrated the utility of the application of integrated analysis using high resolution CGH and whole genome transcript analysis for detecting driver genes in IDC. The high resolution platform allowed a refined demarcation of CNAs and gene expression profiling provided a mechanism to detect genes directly impacted by the CNA. This is the first report of LOH integrated with gene expression in IDC using a high resolution platform.
format Text
id pubmed-2939551
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29395512010-09-16 Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast Hawthorn, Lesleyann Luce, Jesse Stein, Leighton Rothschild, Jenniffer BMC Cancer Research Article BACKGROUND: A major challenge in the interpretation of genomic profiling data generated from breast cancer samples is the identification of driver genes as distinct from bystander genes which do not impact tumorigenesis. One way to assess the relative importance of alterations in the transcriptome profile is to combine parallel analyses that assess changes in the copy number alterations (CNAs). This integrated analysis permits the identification of genes with altered expression that map within specific chromosomal regions which demonstrate copy number alterations, providing a mechanistic approach to identify the 'driver genes'. METHODS: We have performed whole genome analysis of CNAs using the Affymetrix 250K Mapping array on 22 infiltrating ductal carcinoma samples (IDCs). Analysis of transcript expression alterations was performed using the Affymetrix U133 Plus2.0 array on 16 IDC samples. Fourteen IDC samples were analyzed using both platforms and the data integrated. We also incorporated data from loss of heterozygosity (LOH) analysis to identify genes showing altered expression in LOH regions. RESULTS: Common chromosome gains and amplifications were identified at 1q21.3, 6p21.3, 7p11.2-p12.1, 8q21.11 and 8q24.3. A novel amplicon was identified at 5p15.33. Frequent losses were found at 1p36.22, 8q23.3, 11p13, 11q23, and 22q13. Over 130 genes were identified with concurrent increases or decreases in expression that mapped to these regions of copy number alterations. LOH analysis revealed three tumors with whole chromosome or p arm allelic loss of chromosome 17. Genes were identified that mapped to copy neutral LOH regions. LOH with accompanying copy loss was detected on Xp24 and Xp25 and genes mapping to these regions with decreased expression were identified. Gene expression data highlighted the PPARα/RXRα Activation Pathway as down-regulated in the tumor samples. CONCLUSION: We have demonstrated the utility of the application of integrated analysis using high resolution CGH and whole genome transcript analysis for detecting driver genes in IDC. The high resolution platform allowed a refined demarcation of CNAs and gene expression profiling provided a mechanism to detect genes directly impacted by the CNA. This is the first report of LOH integrated with gene expression in IDC using a high resolution platform. BioMed Central 2010-08-27 /pmc/articles/PMC2939551/ /pubmed/20799942 http://dx.doi.org/10.1186/1471-2407-10-460 Text en Copyright ©2010 Hawthorn et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hawthorn, Lesleyann
Luce, Jesse
Stein, Leighton
Rothschild, Jenniffer
Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
title Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
title_full Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
title_fullStr Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
title_full_unstemmed Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
title_short Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
title_sort integration of transcript expression, copy number and loh analysis of infiltrating ductal carcinoma of the breast
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939551/
https://www.ncbi.nlm.nih.gov/pubmed/20799942
http://dx.doi.org/10.1186/1471-2407-10-460
work_keys_str_mv AT hawthornlesleyann integrationoftranscriptexpressioncopynumberandlohanalysisofinfiltratingductalcarcinomaofthebreast
AT lucejesse integrationoftranscriptexpressioncopynumberandlohanalysisofinfiltratingductalcarcinomaofthebreast
AT steinleighton integrationoftranscriptexpressioncopynumberandlohanalysisofinfiltratingductalcarcinomaofthebreast
AT rothschildjenniffer integrationoftranscriptexpressioncopynumberandlohanalysisofinfiltratingductalcarcinomaofthebreast